Background: Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies. A large proportion of surgically-treated patients develop early liver metastasis (LM). We aimed to characterize the incidence of LM and extrahepatic (EH) recurrence and examine peri-operative factors that may affect the liver microenvironment. Methods: We reviewed records of consecutive patients who had R0/R1 pancreatic resection from 2005 to 2009. Based on first recurrence site(s) and timing of LM, patients were classified as: EH only; liver only; EH first-then liver; liver first with EH. Cumulative incidence of first recurrence and time to LM were estimated using competing risks methods. Fine and Gray regression method was used to examine association between peri-operative factors such as BMI, tumor location, biliary obstruction (BO)/drainage, margin status, lymph node ratio and tumor grade with time to LM. Overall survival (OS) from date of surgery was estimated using KaplaneMeier methods. Results: 277 PDAC patients (median age = 70; male = 47%; BO = 67%, of which 76% had drainage procedure; R1 = 22%) were included, with median follow up among survivors of 6 years [range: 0.1e11.3]. A total of 226 deaths were observed at the end of follow up, with 5-year OS of 21% [95% CI: 16%e26%]. 212 patients had recurrence with cumulative incidence of 76% at 5 years. Cumulative incidence of first recurrence at 5 years was 36%, 18%, 11%, and 11% for EH only, liver only, EH first-then liver, and liver first with EH, respectively. Patients with first recurrence in the liver had the worst OS (Figure) . In univariate analysis, only poor tumor differentiation was associated with risk of LM (HR 2.35 [CI: 1.58e3.48]; p < 0.01).
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ePoster Abstracts S145 this retrospective study was to the clinical value of organ preserving pancreatectomy in the treatment of benign or low-grade malignant pancreatic tumor in a single institution. Background: Stage IV metastatic melanoma carries a poor prognosis. In the case of melanoma liver metastasis (MLM), surgical resection may improve survival and represents a therapeutic option, with varying levels of success. Laparoscopic liver resection (LLR) for metastatic melanoma is poorly studied. The aim of this study was to analyze the outcomes of LLR in patients with MLM. Methods: Between April 2000 and August 2013, 11 (1 cutaneous, 9 ocular and 1 unknown primary) patients underwent LLR for MLM at Oslo University Hospital e Rikshospitalet and 13 procedures in total were carried out. Perioperative and oncologic outcomes were analyzed. Postoperative morbidity was classified using the Accordion classification. KaplaneMeier method was used for survival analysis.
Results: A total of 23 liver specimens were resected. The median operative time was 137 (65e470) min, while the median blood loss was less than 50 (<50e900) ml. No intraoperative unfavorable incidents and 30-day mortality occurred. Median follow-up was 33 (9e92) months. Ten patients (91%) developed recurrence within a median of 5 months (2e18 months) and two patients underwent repeat LLR for recurrent liver metastases. One-, three-and fiveyear overall survival rates were 82%, 45% and 9%, respectively. The median overall survival was 30 (9-92) months. 
